Commissioning groups want more support and less red tape

September 29, 2011
NHS reforms

Clinical Commissioning Groups are concerned by the amount of bureaucracy they face and feel they don’t have enough support, according …

Researchers call for European clinical trial reform

September 28, 2011
Research and Development Euorpe, clinical trials

Medical researchers are calling for regulatory red tape to be snipped away from the legal requirements around clinical trials in …

Gardasil

Gardasil better value for money than Cervarix, finds new study

September 28, 2011
Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer

A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …

Lilly launches ‘open innovation’ drug discovery

September 28, 2011
Research and Development OIDD, TB, lilly

Lilly has launched a new open innovation platform designed to help build its pipeline and to identify new treatments for …

SHL to speak at the upcoming Drug Delivery Trends symposium in Korea

September 28, 2011
Manufacturing and Production auto injector, autoinjector, drugy delivery, pharmapack

SHL Marketing Director Steven Kaufman will be speaking at the upcoming Primary Packaging and Drug Delivery Trends for Injectables symposium …

Cancer costs on an ‘unaffordable trajectory’

September 28, 2011
Sales and Marketing Cancer, healthcare costs

The cost of cancer is rising too fast with new treatments giving uncertain benefits, according to a new study. A …

Roche’s Herceptin successor impresses at EMCC

September 27, 2011
Research and Development Herceptin, Roche, TDM-1

Roche’s next-generation breast cancer drug T-DM1 has impressed at the European cancer congress after besting Herceptin in a new study. …

Boehringer Ingelheim

Boehringer to create biosimilars division

September 27, 2011
Research and Development Boehringer, biosimilars

Boehringer Ingelheim is to tap into the growing interest in biosimilars with the creation of a division dedicated to that …

MTS Medication Technologies appoints Paul O’Hanlon

September 27, 2011
Manufacturing and Production appointments, manufacturing and production

MTS Medication Technologies has appointed Paul O’Hanlon as managing director of its International Division. He has 27 years of experience …

Lonza signs regenerative medicine deal with Mesoblast

September 27, 2011
Manufacturing and Production Lonza, Mesoblast, pharma manufacturing news

Lonza has entered into a strategic-level alliance with Mesoblast, a specialist in regenerative medicines, which could see the construction of …

SCM Pharma unveils formulation development business

September 27, 2011
Manufacturing and Production SCM Pharma, phamra manufacturing news, pharma manufacturing news

UK contract manufacturer SCM Pharma has set up a formulation development business, thanks to a collaboration with the University of …

Pharma manufacturing news in brief

September 26, 2011
Manufacturing and Production pharma manufacturing news

This week’s roundup includes contract manufacturing updates from CMC Biologics, West-Ward and Aenova, plus a Catalent deal in Japan and …

Bridgehead International appoints Marcus Deans

September 26, 2011
Sales and Marketing appointment, sales and marketing

London-based consultants Bridgehead International have appointed Marcus Deans as principal consultant. He joins the firm, which specialises in market access, …

Xarelto poised for two new chronic indications

September 26, 2011
Sales and Marketing Xarelto

Bayer HealthCare’s oral bloodthinner Xarelto has been recommended for approval in Europe for two new chronic indications. The Committee for …

Roche’s Avastin set for new ovarian cancer indication in Europe

September 26, 2011
Sales and Marketing avastin, ovarian cancer

Roche’s Avastin has gained the backing of European regulatory advisors for a new indication in ovarian cancer. The European Medicines …

Sanofi's Multaq

Safety concerns prompt Multaq restrictions

September 26, 2011
Sales and Marketing Multaq

The European Medicines Agency has recommended Sanofi’s Multaq be restricted due to ongoing concerns about its safety profile. The drug …

Roche's Avastin

Avastin faces greater scrutiny over eye disease use

September 23, 2011
Sales and Marketing avastin, macular oedema

The use of Roche’s Avastin to treat eye disease has come under greater scrutiny after a series of infections in …

Carolin Prasmo returns to Aurora

September 23, 2011
Medical Communications appointment, medical communications

Farringdon, UK-based comms agency Aurora has appointed Carolin Prasmo as senior account account manager. She was originally one of the …

virgo_health_education_jenny_szkolar

Virgo Health Education expands scientific and client service teams

September 23, 2011
Medical Communications appointment, medical communications

Virgo has expanded its Health Education business unit with the appointments of Jenny Szkolar and Vicky Cadman. Jenny (pictured) joins …

Boehringer censured over Pradaxa marketing

September 23, 2011
Medical Communications ABPI Code of Practice, Boehringer

Boehringer Ingelheim has been heavily censured by the body which enforces the ABPI’s Code of Practice for the content of …

The Gateway to Local Adoption Series

Latest content